148 related articles for article (PubMed ID: 24363950)
41. Anti-GBM disease after nephrectomy for xanthogranulomatous pyelonephritis in a patient expressing HLA DR15 major histocompatibility antigens: a case report.
O'Hagan E; Mallett T; Convery M; McKeever K
Clin Nephrol Case Stud; 2015; 3():25-30. PubMed ID: 29043130
[TBL] [Abstract][Full Text] [Related]
42. Patient with antibody-negative relapse of Goodpasture syndrome.
Benz K; Amann K; Dittrich K; Hugo C; Schnur K; Dötsch J
Clin Nephrol; 2007 Apr; 67(4):240-4. PubMed ID: 17474560
[TBL] [Abstract][Full Text] [Related]
43. Antiglomerular basement membrane antibody-mediated glomerulonephritis and Goodpasture's syndrome.
Briggs WA; Johnson JP; Teichman S; Yeager HC; Wilson CB
Medicine (Baltimore); 1979 Sep; 58(5):348-61. PubMed ID: 384140
[TBL] [Abstract][Full Text] [Related]
44. Antiglomerular basement membrane (anti-GBM) disease with clinical and histological features that bridge the typical to atypical spectrum.
Fouhy F; Mayer N; Burke L; O'Shaughnessy M
BMJ Case Rep; 2021 Jul; 14(7):. PubMed ID: 34257112
[TBL] [Abstract][Full Text] [Related]
45. Concurrent antiglomerular basement membrane antibody and immune complex mediated glomerulonephritis.
Jennette JC; Lamanna RW; Burnette JP; Wilkman AS; Iskander SS
Am J Clin Pathol; 1982 Sep; 78(3):381-6. PubMed ID: 6180630
[TBL] [Abstract][Full Text] [Related]
46. SARS-CoV-2 infection and recurrence of anti-glomerular basement disease: a case report.
Winkler A; Zitt E; Sprenger-Mähr H; Soleiman A; Cejna M; Lhotta K
BMC Nephrol; 2021 Feb; 22(1):75. PubMed ID: 33639869
[TBL] [Abstract][Full Text] [Related]
47. Atypical antiglomerular basement membranes disease with nephrotic-range proteinuria, mesangial proliferation, and membranoproliferative glomerulonephritis pattern of injury.
AlSowailmi B; AlSowailmi G; Aloudah N; Alsaad KO; Elhassan E; Al Sayyari AA
Saudi J Kidney Dis Transpl; 2017; 28(6):1397-1403. PubMed ID: 29265053
[TBL] [Abstract][Full Text] [Related]
48. [Anti-glomerular basement membrane antibody-mediated glomerulonephritis remarkably improved by pulse therapy with methylprednisolone, plasmapheresis and continuous heparin infusion].
Takashima K; Syukuwa S; Iwanaga N; Sakata H; Yasumori R; Tadokoro M; Kohara S; Tanaka T; Matsuo S; Muraya Y
Nihon Jinzo Gakkai Shi; 1989 Nov; 31(11):1197-204. PubMed ID: 2625742
[TBL] [Abstract][Full Text] [Related]
49. Successful treatment of resistant antiglomerular basement membrane antibody positivity with mycophenolic acid.
Kiykim AA; Horoz M; Gok E
Intern Med; 2010; 49(6):577-80. PubMed ID: 20228594
[TBL] [Abstract][Full Text] [Related]
50. Allograft antiglomerular basement membrane glomerulonephritis in a patient with Alport's syndrome.
Teruel JL; Liaño F; Mampaso F; Moreno J; Serrano A; Quereda C; Ortuño J
Nephron; 1987; 46(1):43-4. PubMed ID: 3299117
[TBL] [Abstract][Full Text] [Related]
51. Posttransplant anti-glomerular basement membrane nephritis in related males with Alport syndrome.
Kashtan CE; Butkowski RJ; Kleppel MM; First MR; Michael AF
J Lab Clin Med; 1990 Oct; 116(4):508-15. PubMed ID: 2212860
[TBL] [Abstract][Full Text] [Related]
52. The pathogenesis of Alport syndrome involves type IV collagen molecules containing the alpha 3(IV) chain: evidence from anti-GBM nephritis after renal transplantation.
Hudson BG; Kalluri R; Gunwar S; Weber M; Ballester F; Hudson JK; Noelken ME; Sarras M; Richardson WR; Saus J
Kidney Int; 1992 Jul; 42(1):179-87. PubMed ID: 1635348
[TBL] [Abstract][Full Text] [Related]
53. Anti-glomerular basement membrane disease mediated by IgG and IgA: a case report.
Zou G; Lu H; Zhuo L; Zou W; Li W
Ren Fail; 2021 Dec; 43(1):774-778. PubMed ID: 33913397
[TBL] [Abstract][Full Text] [Related]
54. Atypical anti-glomerular basement membrane glomerulonephritis in a patient with metastatic melanoma treated with mitogen-activated protein kinase and immune checkpoint inhibitors: a case report.
Kyriazis P; Tiwary A; Freeman J; Landry D; Braden G
J Med Case Rep; 2021 Apr; 15(1):186. PubMed ID: 33810799
[TBL] [Abstract][Full Text] [Related]
55. Characteristics and outcome of crescentic glomerulonephritis in patients with both antineutrophil cytoplasmic antibody and anti-glomerular basement membrane antibody.
Srivastava A; Rao GK; Segal PE; Shah M; Geetha D
Clin Rheumatol; 2013 Sep; 32(9):1317-22. PubMed ID: 23624587
[TBL] [Abstract][Full Text] [Related]
56. [Goodpasture's syndrome with neurologic involvement and negative ANCA].
Pérez-Suárez G; Marrero D; Rodríguez R; Delgado P; Cobo M; González-Posada JM; Hernández D
Nefrologia; 2010; 30(5):584-7. PubMed ID: 20613848
[TBL] [Abstract][Full Text] [Related]
57. Proliferative glomerulonephritis with linear immunoglobulin deposition: is this atypical antiglomerular basement membrane disease?
Teixeira AC; Pinto H; Oliveira N; Marinho C
BMJ Case Rep; 2018 May; 2018():. PubMed ID: 29724870
[TBL] [Abstract][Full Text] [Related]
58. IgA antiglomerular basement membrane disease associated with bronchial carcinoma and monoclonal gammopathy.
Maes B; Vanwalleghem J; Kuypers D; Van Damme B; Waer M; Vanrenterghem Y
Am J Kidney Dis; 1999 Feb; 33(2):E3. PubMed ID: 10074603
[TBL] [Abstract][Full Text] [Related]
59. A Case of De Novo Antiglomerular Basement Membrane Disease Presenting during Pregnancy.
Lodhi FAK; Akcan T; Mojarrab JN; Sajjad S; Blonsky R
Case Rep Nephrol; 2021; 2021():5539205. PubMed ID: 33815854
[No Abstract] [Full Text] [Related]
60. Presence of Anti-Glomerular Basement Membrane Antibodies and Myeloperoxidase Anti-Neutrophilic Cytoplasmic Antibodies in a Case of Rapidly Progressive Glomerulonephritis.
Mavani GP; Pommier M; Win S; Michelis MF; Rosenstock J
Front Med (Lausanne); 2015; 2():53. PubMed ID: 26301224
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
